A 2-year prospective follow-up study of the course of obsessive-compulsive disorder
- PMID: 20797381
- PMCID: PMC4083757
- DOI: 10.4088/JCP.08m04806blu
A 2-year prospective follow-up study of the course of obsessive-compulsive disorder
Abstract
Background: Surprisingly little is known about the long-term course of obsessive-compulsive disorder (OCD). This prospective study presents 2-year course findings, as well as predictors of course, from the Brown Longitudinal Obsessive Compulsive Study, the first comprehensive prospective investigation of the observational course of OCD in a large clinical sample.
Method: The sample included 214 treatment-seeking adults with DSM-IV OCD at intake who identified OCD as the most problematic disorder over their lifetime. Subjects were enrolled from 2001-2004. At annual interviews, data on weekly OCD symptom status were obtained using the Longitudinal Interval Follow-Up Evaluation. Probabilities of full remission and partial remission over the first 2 years of collected data and potential predictors of remission were examined.
Results: The probability of full remission from OCD was 0.06, and the probability of partial remission was 0.24. Of the 48 subjects whose OCD symptoms partially or fully remitted, only 1 relapsed within the first 2 years. Earlier age at onset of OCD, greater severity of symptoms at intake, older age at intake, and being male were associated with a decreased likelihood of remission. Insight, diagnostic comorbidity, and treatment were not found to be associated with the likelihood of achieving full or partial remission.
Conclusions: Though one-quarter of the sample had periods of subclinical OCD symptoms during the prospective period, full remission was rare, consistent with the view of OCD as a chronic and persistent illness. Age at onset, OCD symptom severity, current age, and sex emerged as potent predictors of course.
Copyright 2010 Physicians Postgraduate Press, Inc.
Similar articles
-
Five-year course of obsessive-compulsive disorder: predictors of remission and relapse.J Clin Psychiatry. 2013 Mar;74(3):233-9. doi: 10.4088/JCP.12m07657. J Clin Psychiatry. 2013. PMID: 23561228 Free PMC article.
-
The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake.J Clin Psychiatry. 2006 May;67(5):703-11. doi: 10.4088/jcp.v67n0503. J Clin Psychiatry. 2006. PMID: 16841619 Free PMC article.
-
Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study.J Clin Psychiatry. 1999 May;60(5):346-51; quiz 352. doi: 10.4088/jcp.v60n0514. J Clin Psychiatry. 1999. PMID: 10362449 Clinical Trial.
-
[Obsessive-compulsive Disorder: Prevalence, Comorbidity and Remission from the Ages of 20 to 50].Praxis (Bern 1994). 2015 Nov 25;104(24):1323-8. doi: 10.1024/1661-8157/a002205. Praxis (Bern 1994). 2015. PMID: 26602849 Review. German.
-
Pediatric obsessive-compulsive disorder: management priorities in primary care.Curr Opin Pediatr. 2008 Oct;20(5):544-50. doi: 10.1097/MOP.0b013e32830f93d9. Curr Opin Pediatr. 2008. PMID: 18781117 Review.
Cited by
-
Brazilian research consortium on obsessive-compulsive spectrum disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part II: Cognitive-Behavior Therapy treatment.Braz J Psychiatry. 2023 Sep 17;45(5):431-47. doi: 10.47626/1516-4446-2023-3081. Online ahead of print. Braz J Psychiatry. 2023. PMID: 37718254 Free PMC article.
-
Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive-compulsive disorder.Neuropsychiatr Dis Treat. 2018 Aug 10;14:2027-2038. doi: 10.2147/NDT.S173388. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30127613 Free PMC article.
-
Movie- and mobile-therapy without therapist involvment for patients with obsessive-compulsive disorder: Protocol for a randomized controlled trial.PCN Rep. 2025 Feb 16;4(1):e70065. doi: 10.1002/pcn5.70065. eCollection 2025 Mar. PCN Rep. 2025. PMID: 39963546 Free PMC article.
-
Prevalence and clinical characteristics of mental rituals in a longitudinal clinical sample of obsessive-compulsive disorder.Depress Anxiety. 2011 Oct 3;28(10):892-8. doi: 10.1002/da.20869. Epub 2011 Aug 4. Depress Anxiety. 2011. PMID: 21818825 Free PMC article.
-
Epidemiological and Clinical Gender Differences in OCD.Curr Psychiatry Rep. 2019 Apr 23;21(5):36. doi: 10.1007/s11920-019-1015-2. Curr Psychiatry Rep. 2019. PMID: 31016410 Review.
References
-
- Marks IM, Hodgson R, Rachman S. Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure: a two-year follow-up and issues in treatment. Br J Psychiatry. 1975;127(4):349–364. doi:10.1192/bjp.127.4.349 PubMed. - PubMed
-
- O'Sullivan G, Noshirvani H, Marks I, et al. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. J Clin Psychiatry. 1991;52(4):150–155. PubMed. - PubMed
-
- Mindus P, Rasmussen SA, Lindquist C. Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. J Neuropsychiatry Clin Neurosci. 1994;6(4):467–477. PubMed. - PubMed
-
- Alonso P, Menchon JM, Pifarre J, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry. 2001;62(7):535–540. PubMed. - PubMed
-
- van Oppen P, van Balkom AJ, de Haan E, et al. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. J Clin Psychiatry. 2005;66(11):1415–1422. doi:10.4088/JCP.v66n1111 PubMed. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical